DEV

You are viewing our development site. Please share feedback with support@dosevault.ai or on our Discord server. See what is new in the changelog.

Recovery

Larazotide Acetate

Tight-junction regulator developed for celiac disease; reduces intestinal permeability.

Molecular Profile
linear
8 AA Sequence
CAS
881851-50-9
Mol. weight
784.9 g/mol
Formula
C39H56N10O15
Chain length
8 aa
Sequence
GGVLVQPG
Onset and duration

No acute perceptible effect; reported benefits build over days to weeks of consistent use.

Storage and reconstitution

Store the lyophilized powder refrigerated (2 to 8 C), or frozen for long-term storage, protected from light. After reconstitution with bacteriostatic water, keep refrigerated and use within about 4 weeks.

Clinical Evidence

What the literature says

Scientific Overview

Larazotide acetate (AT-1001) is an octapeptide zonulin antagonist that prevents tight-junction disassembly in the small intestine. Innovate Biopharmaceuticals advanced it to Phase 3 (CeDLara) as an adjunct for celiac disease but the trial failed its primary endpoint in 2022, and the program was paused. Still studied in long COVID and IBS.

Research Guide

How users approach this compound

The following reflects patterns observed in research literature and community protocols. This is not medical advice and does not constitute a clinical recommendation.

Research Protocols

Common Dosages

Celiac (research)

0.5 mg
3x daily, oral

Before meals

Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Key Research Benefits

  • Tightens intestinal junctions
  • Reduces leaky-gut markers
  • Studied in celiac disease

Potential Side Effects

Headache
Nausea
Upper respiratory symptoms

Labs to monitor

Educational context only, not a testing mandate. Any bloodwork decisions belong with your clinician.

  • No validated compound-specific markers: No standard bloodwork is established for this compound; general safety labs (CBC, comprehensive metabolic panel) are reasonable if used under medical supervision.

Dose Calculator

Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

20 Units

or 0.20 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Stack Larazotide Acetatewith…

Curated stacking partners researched alongside Larazotide Acetate. Each link opens a dedicated stack page with combined benefits, side-effect overlap, and half-life considerations.

Larazotide Acetate by goal

Read Larazotide Acetate's profile filtered through specific research goals.

Related Tools

Not medical advice

Information on DoseVault is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider.